ChiCTR2000029573: A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection |
|
|
| Recruiting | 4 | 480 | China | antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization ;antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization | The First Affiliated Hospital of Medical College of Zhejiang University; The First Affiliated Hospital of Medical College of Zhejiang University, coordinater | novel coronavirus pneumonia | | | | |
